Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay?

TheMotleyFool

0 0

Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay?

Axsome Therapeutics (NASDAQ: AXSM) recently announced that the U.S. Food and Drug Administration (FDA) wouldn't make an approval decision on AXS-05 for treating major depressive disorder as quickly as hoped. In this Motley Fool Live video recorded on Aug. 25, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether Axsome stock is a buy, sell, or hold after this FDA delay.

Source Fool.com

Like: 0

AXSM

Share